S. Kailasam

446 total citations
18 papers, 359 citations indexed

About

S. Kailasam is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, S. Kailasam has authored 18 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in S. Kailasam's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). S. Kailasam is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). S. Kailasam collaborates with scholars based in United States and India. S. Kailasam's co-authors include P R Gangadharam, A. Narayana, G.R.K. Sarma, Chandra Immanuel, Prem Venkatesan, S. Radhakrishna, M. V. R. Reddy, Chinnaswamy Jagannath, John O’Sullivan and Donald L. Wise and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Chemosphere and Journal of Controlled Release.

In The Last Decade

S. Kailasam

17 papers receiving 321 citations

Peers

S. Kailasam

EPIDE

PHARM

ONCOL

Alan E. Hassell United States

Patricia T. Gammon United Kingdom

Dennis H. Giesing United States

Lois Jessen United States

Souzan B. Yanni United States

H. Scheijgrond Belgium

Araz Raoof Belgium

Sou-Yie Chu United States

Hasse Schröder Sweden

Chandra Immanuel India

Alan E. Hassell United States

S. Kailasam

173 ×1.2

140 ×1.2

EPIDE

46 ×0.4

PHARM

40 ×0.6

ONCOL

43 ×0.9

Citations per year, relative to S. Kailasam S. Kailasam (= 1×) peers Alan E. Hassell

Countries citing papers authored by S. Kailasam

Since Specialization

Citations

This map shows the geographic impact of S. Kailasam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kailasam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kailasam more than expected).

Fields of papers citing papers by S. Kailasam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kailasam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kailasam. The network helps show where S. Kailasam may publish in the future.

Co-authorship network of co-authors of S. Kailasam

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kailasam. A scholar is included among the top collaborators of S. Kailasam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kailasam. S. Kailasam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Immanuel, Chandra, et al.. (2015). Rifampin-lnduced Release of Hydrazine from Isoniazid. American Review of Respiratory Disease. 2 indexed citations

Kailasam, S. & Kim R. Rogers. (2006). A fluorescence-based screening assay for DNA damage induced by genotoxic industrial chemicals. Chemosphere. 66(1). 165–171. 18 indexed citations

Jagannath, Chinnaswamy, M. V. R. Reddy, S. Kailasam, John O’Sullivan, & P R Gangadharam. (1995). Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies.. American Journal of Respiratory and Critical Care Medicine. 151(4). 1083–1086. 68 indexed citations

Kailasam, S., Donald L. Wise, & P R Gangadharam. (1994). Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer. Journal of Antimicrobial Chemotherapy. 33(2). 273–279. 20 indexed citations

Kailasam, S., et al.. (1994). Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer. Tubercle and Lung Disease. 75(5). 361–365. 21 indexed citations

Gangadharam, P R, et al.. (1994). Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers. Journal of Antimicrobial Chemotherapy. 33(2). 265–271. 13 indexed citations

Gangadharam, P R, et al.. (1993). Release of isoniazid for prolonged periods from a biodegradable polymer under several in vitro and simulated in vivo conditions and in animals. Journal of Controlled Release. 26(2). 87–98. 5 indexed citations

Sarma, G.R.K., et al.. (1990). Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.. PubMed. 27(2). 134–42. 9 indexed citations

Sarma, G.R.K., Chandra Immanuel, S. Kailasam, A. Narayana, & Prem Venkatesan. (1986). Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.. PubMed. 133(6). 1072–5. 90 indexed citations

10.

Sarma, G.R.K., S. Kailasam, Nitin Nair, A. Narayana, & Srikanth Tripathy. (1980). Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid. Antimicrobial Agents and Chemotherapy. 18(5). 661–666. 28 indexed citations

11.

Kailasam, S., et al.. (1976). Classification of subjects as slow or rapid inactivators of isoniazid based on the ratio of acetylisoniazid to isoniazid in urine determined by a simple colorimetric method.. PubMed. 64(10). 1456–61. 3 indexed citations

12.

Kailasam, S., Chandra Immanuel, Nitin Nair, S. Radhakrishna, & Srikanth Tripathy. (1975). Classification of subjects as slow or rapid inactivators of isoniazid oral administration of a slow-release preparation of isoniazid and determination of the ratio of acetylisoniazid to isoniazid in urine.. PubMed. 63(2). 323–8. 8 indexed citations

13.

Kailasam, S., et al.. (1975). Studies of serial plasma isoniazid concentrations with different doses of a slow-release preparation of isoniazid. Tubercle. 56(4). 314–323. 5 indexed citations

14.

Immanuel, Chandra, et al.. (1974). A modified method for the estimation of acetylisoniazid in urine.. PubMed. 62(6). 945–52. 11 indexed citations

15.

Kailasam, S., et al.. (1971). Inactivation of isoniazid by condensation in a syrup preparation.. PubMed. 59(9). 1343–53. 28 indexed citations

16.

Kailasam, S., et al.. (1971). Inactivation of isoniazid by condensation in a syrup preparation.. PubMed. 45(5). 625–32. 17 indexed citations

17.

Kailasam, S., et al.. (1968). A simple qualitative test for deterioration of cycloserine.. PubMed. 39(5). 842–4. 1 indexed citations

18.

Eidus, L, S. Kailasam, S. Radhakrishna, et al.. (1968). Deterioration of cycloserine in the tropics.. PubMed. 39(5). 781–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact